<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="551">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03099694</url>
  </required_header>
  <id_info>
    <org_study_id>Jiulongpo People's Hospital</org_study_id>
    <nct_id>NCT03099694</nct_id>
  </id_info>
  <brief_title>NHFOV vs. NCPAP as a Primary Treatment to Neonatal Respiratory Distress Syndrome(NRDS)</brief_title>
  <official_title>Noninvasive Ventilation for Preterm Neonates With Respiratory Distress Syndrome: a Multi-center Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xingwang Zhu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Guiyang Maternity and Child Health Care Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Daping Hospital and the Research Institute of Surgery of the Third Military Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital of Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chongqing Maternal and Child Health Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second Hospital of Shandong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Jiulongpo No.1 People's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators compared advantages and disadvantages of two forms of noninvasive
      respiratory support —noninvasive high-frequency ventilation (nHFV) or nasal continuous
      positive airway pressure (nCPAP) —as a primary mode of ventilation in premature infants with
      RDS．
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators enrolled preterm infants at 8 neonatal intensive care units in China.
      Infants were eligible if they had a gestational age of less than 35 weeks and if they were
      RDS candidates for noninvasive respiratory support. Infants were excluded if they were
      diagnosed as white lung, had congenital abnormalities, or had hypercapnia.

      The parameters such as the concentration of inhalation oxygen (FiO2) were adjusted according
      to percutaneous oxygen saturation or blood gas analysis.The primary outcome was ratio of
      intubation if failed non-invasive ventilation, period of non-invasive ventilation if succeed
      non-invasive ventilation, morbidity of bronchopulmonary dysplasia.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 2017</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ratio of intubation</measure>
    <time_frame>during non-invasive ventilation</time_frame>
    <description>ratio of intubation for invasive ventilation if failed non-invasive ventilation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the incidence of intraventricular hemorrhage</measure>
    <time_frame>first two months after birth</time_frame>
    <description>do brain ultrasound in the first and second week after birth,do brain MRI when corrected gestational age is 40 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the incidence of pneumothorax</measure>
    <time_frame>during non-invasive ventilation</time_frame>
    <description>the incidence of pneumothorax</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the incidence of neonatal necrotizing enterocolitis</measure>
    <time_frame>during non-invasive ventilation</time_frame>
    <description>the incidence and grade of neonatal necrotizing enterocolitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the incidence of retinopathy of prematurity</measure>
    <time_frame>3 months after birth</time_frame>
    <description>the incidence and grade of retinopathy of prematurity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bayley Scales of Infant Development</measure>
    <time_frame>30 months</time_frame>
    <description>scores of Bayley Scales of Infant Development</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the incidence of bronchopulmonary dysplasia(BPD)</measure>
    <time_frame>28 days after birth</time_frame>
    <description>the incidence and grade of bronchopulmonary dysplasia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Preterm Infants</condition>
  <arm_group>
    <arm_group_label>nCPAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>nasal continuous positive airway pressure (nCPAP) —as a primary mode of ventilation in premature infants with RDS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>nHFOV</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>noninvasive high-frequency ventilation (nHFOV) as a primary mode of ventilation in premature infants with RDS</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>noninvasive high-frequency ventilation (nHFOV)</intervention_name>
    <description>noninvasive high-frequency ventilation (nHFOV) as a primary mode of ventilation in premature infants with RDS</description>
    <arm_group_label>nHFOV</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>nasal continuous positive airway pressure (nCPAP)</intervention_name>
    <description>nasal continuous positive airway pressure (nCPAP) as a primary mode of ventilation in premature infants with RDS</description>
    <arm_group_label>nCPAP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gestational age &lt; 35 weeks;

          -  Diagnosed as neonatal respiratory distress syndrome;

          -  Inhalation of atmospheric conditions, blood oxygen partial pressure (PaO2) &lt;6.7kPa

        Exclusion Criteria:

          -  Neonatal respiratory distress syndrome Grade Ⅳ(White Lung);

          -  Hypercapnia（pH&lt;7.20, PaCO2﹥8.0kPa);

          -  Respiratory malformations or Complexity of congenital heart disease;

          -  Severe circulatory dysfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>24 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shi Yuan, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Third Military Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhu Xingwang, MD</last_name>
    <phone>+8615084335697</phone>
    <email>15084335697@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shi Yuan, PhD</last_name>
    <phone>+8613508300283</phone>
    <email>petshi530@vip.163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Xingwang Zhu</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhu Xingwang, MD</last_name>
      <phone>+8615084335697</phone>
      <email>15084335697@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Shi Yuan, PhD</last_name>
      <phone>(023)68757731</phone>
      <email>petshi530@vip.163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>April 3, 2017</lastchanged_date>
  <firstreceived_date>November 17, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Jiulongpo No.1 People's Hospital</investigator_affiliation>
    <investigator_full_name>Xingwang Zhu</investigator_full_name>
    <investigator_title>Director of neonatology</investigator_title>
  </responsible_party>
  <keyword>NRDS</keyword>
  <keyword>nHFV</keyword>
  <keyword>nCPAP</keyword>
  <keyword>preterm infants</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Hyaline Membrane Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
